- Home
- ALVO vs AHCO Comparison
ALVO vs AHCO Comparison
Compare ALVO & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALVO | AHCO |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | Luxembourg | United States |
| Employees | 1460 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALVO | AHCO |
|---|---|---|
| Price | $3.46 | $10.27 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $8.00 | ★ $13.50 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,244,857,000.00 |
| Revenue This Year | $13.28 | $9.00 |
| Revenue Next Year | $18.63 | $6.93 |
| P/E Ratio | $18.20 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.94 | $8.51 |
| 52 Week High | $9.94 | $13.43 |
Technical Indicators
Market Signals| Indicator | ALVO | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 44.26 | 50.12 |
| Support Level | $3.09 | $9.50 |
| Resistance Level | $3.83 | $10.48 |
| Average True Range (ATR) | 0.23 | 0.39 |
| MACD | -0.05 | 0.13 |
| Stochastic Oscillator | 5.06 | 55.48 |
Price Performance
Historical ComparisonAbout ALVO Alvotech
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.